PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 10, 2026European Journal of Endocrinology4 citations

Evaluating the Impact of Adrenalectomy and Mineralocorticoid Receptor Antagonists for Primary Aldosteronism on Left Ventricular Remodeling: A Systematic Review and Meta-Analysis

YCYu‐Cheng ChangUCUei-Lin ChenCHChi-Sheng Hung

Key Result

Adrenalectomy reduced left ventricular mass index (LVMI) more than MRAs by a difference-in-difference SMD of -0.15, highlighting its effectiveness in patients with primary aldosteronism.

Key Points

  • This meta-analysis compares the effects of adrenalectomy and mineralocorticoid receptor antagonists on left ventricular remodeling in patients with primary aldosteronism.
  • Systematic review of MEDLINE, Embase, and Cochrane databases for relevant studies
  • Analysis included patients with primary aldosteronism receiving either adrenalectomy or MRAs
  • Evaluated reduction in left ventricular mass index as the main outcome
  • 1,197 patients included across 10 studies
  • Both adrenalectomy and MRAs resulted in improved left ventricular mass index
  • Adrenalectomy showed a greater reduction in left ventricular mass index compared to MRAs
  • MRA optimization's effect on left ventricular mass index remains uncertain

Structured PICO

Does adrenalectomy improve left ventricular mass index reduction compared to mineralocorticoid receptor antagonists in patients with primary aldosteronism?

P
Population
1,197 patients with primary aldosteronism (PA) pooled from 10 studies
I
Intervention
Adrenalectomy
C
Comparator
Mineralocorticoid receptor antagonists (MRAs)
O
Outcome
Reduction in left ventricular mass index (LVMI) after treatmentsurrogate

In patients with primary aldosteronism, both adrenalectomy and MRAs improve left ventricular remodeling, but adrenalectomy is associated with slightly greater reductions in left ventricular mass index, particularly in unilateral disease.

Limitations

  • Small effect size
  • Impact of MRA optimization could not be assessed

Abstract

Abstract Background Primary aldosteronism (PA) is characterized by autonomous aldosterone production, which leads to left ventricular (LV) remodeling and adverse cardiovascular outcomes. This meta-analysis aimed to compare the effects of two treatment strategies, mineralocorticoid receptor antagonists (MRAs) and adrenalectomy, on the regression of LV remodeling in patients with PA. Methods MEDLINE, Embase, and Cochrane databases were searched for studies reporting the effect of adrenalectomy or medical therapy on reversing LV mass index (LVMI) in patients with PA. The outcome of interest was the reduction in LVMI after treatment. Results A total of 1,197 patients with PA from 10 studies were included in the analysis. The meta-analysis demonstrated that both adrenalectomy and MRAs improved LVMI in patients with PA (adrenalectomy: standardized mean difference SMD = -0.49, 95% CI = -0.65 to -0.33; MRAs: SMD = -0.35, 95% CI = -0.48 to -0.22). The reduction in LVMI was greater following adrenalectomy in direct comparison analyses (difference-in-difference SMD = -0.15, 95% CI: -0.26 to -0.03). However, the effect size was small, and the impact of MRA optimization could not be assessed. In studies focusing specifically on unilateral PA, adrenalectomy demonstrated greater LVMI reduction than MRAs. Conclusions This meta-analysis suggests that both adrenalectomy and MRAs improve LV remodeling. Although adrenalectomy was generally associated with slightly greater LVMI reductions than MRAs, the impact of optimized MRA therapy on LVMI reduction remains uncertain. When focusing specifically on patients with unilateral PA, adrenalectomy was associated with more pronounced regression of LV remodeling compared with MRA therapy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chang et al. (2026) studied this question. Adrenalectomy reduced left ventricular mass index (LVMI) more than MRAs by a difference-in-difference SMD of -0.15, highlighting its effectiveness in patients with primary aldosteronism.

synapsesocial.com/papers/696321e591e05aa366cb82f1https://doi.org/10.1093/ejendo/lvaf271
Ask AI
Helpful
Bookmark
Share
View Full Paper